These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34604725)

  • 1. Ablation of liver
    Ijssennagger N; van Rooijen KS; Magnúsdóttir S; Ramos Pittol JM; Willemsen ECL; de Zoete MR; Baars MJD; Stege PB; Colliva C; Pellicciari R; Youssef SA; de Bruin A; Vercoulen Y; Kuipers F; van Mil SWC
    JHEP Rep; 2021 Oct; 3(5):100344. PubMed ID: 34604725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
    Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
    J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
    Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice.
    Li S; Zhuge A; Chen H; Han S; Shen J; Wang K; Xia J; Xia H; Jiang S; Wu Y; Li L
    J Adv Res; 2024 Apr; ():. PubMed ID: 38582300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
    Gadaleta RM; van Erpecum KJ; Oldenburg B; Willemsen EC; Renooij W; Murzilli S; Klomp LW; Siersema PD; Schipper ME; Danese S; Penna G; Laverny G; Adorini L; Moschetta A; van Mil SW
    Gut; 2011 Apr; 60(4):463-72. PubMed ID: 21242261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid nuclear receptor FXR and digestive system diseases.
    Ding L; Yang L; Wang Z; Huang W
    Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPA and DHA differentially coordinate the crosstalk between host and gut microbiota and block DSS-induced colitis in mice by a reinforced colonic mucus barrier.
    Fang J; Zhang Z; Cheng Y; Yang H; Zhang H; Xue Z; Lu S; Dong Y; Song C; Zhang X; Zhou Y
    Food Funct; 2022 Apr; 13(8):4399-4420. PubMed ID: 35297435
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesenchymal stem cell-derived exosome mitigates colitis
    Ocansey DKW; Zhang Z; Xu X; Liu L; Amoah S; Chen X; Wang B; Zhang X; Mao F
    Biomater Sci; 2022 Aug; 10(17):4822-4836. PubMed ID: 35858469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatilla decoction alleviates DSS-induced UC by activating FXR-ASBT pathways to ameliorate disordered bile acids homeostasis.
    Xiao Y; Jia YQ; Liu WJ; Niu C; Mai ZH; Dong JQ; Zhang XS; Yuan ZW; Ji P; Wei YM; Hua YL
    Front Pharmacol; 2024; 15():1399829. PubMed ID: 38974033
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Sun X; Chen Z; Yu L; Zeng W; Sun B; Fan H; Bai Y
    Front Pharmacol; 2023; 14():1205323. PubMed ID: 37292154
    [No Abstract]   [Full Text] [Related]  

  • 12. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
    Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.
    Li G; L Guo G
    Acta Pharm Sin B; 2015 Mar; 5(2):93-8. PubMed ID: 26579433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome.
    Feng L; Zhang W; Shen Q; Miao C; Chen L; Li Y; Gu X; Fan M; Ma Y; Wang H; Liu X; Zhang X
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1553-1569. PubMed ID: 34585527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor.
    Tang K; Kong D; Peng Y; Guo J; Zhong Y; Yu H; Mai Z; Chen Y; Chen Y; Cui T; Duan S; Li T; Liu N; Zhang D; Ding Y; Huang J
    Front Pharmacol; 2022; 13():1000444. PubMed ID: 36386150
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
    J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis.
    Han B; Lv X; Liu G; Li S; Fan J; Chen L; Huang Z; Lin G; Xu X; Huang Z; Zhan L; Lv X
    Gut Microbes; 2023; 15(1):2232143. PubMed ID: 37431863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesoid X Receptor Agonist GW4064 Protects Lipopolysaccharide-Induced Intestinal Epithelial Barrier Function and Colorectal Tumorigenesis Signaling through the αKlotho/βKlotho/FGFs Pathways in Mice.
    Liu HM; Chang ZY; Yang CW; Chang HH; Lee TY
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.